Subscribe to RSS

DOI: 10.1055/s-0042-1742372
Challenges in the Histopathologic Diagnosis of Brain Tumors: An Institutional Experience in a Series of Cases

Abstract
Background Central nervous system (CNS) tumors are relatively rare. However, brain tumors are one of the leading causes of cancer-related morbidity and mortality. Accurate histopathologic diagnosis and molecular diagnostics are critical for managing these patients. Histopathology plays a vital role in diagnosis, but clinical and radiological information is also crucial while evaluating brain tumors.
Materials and Methods A cross-sectional observational study was performed for a period of 1 year in the pathology department of a tertiary hospital. All the brain biopsies sent for histopathological analysis were analyzed, and among which five brain biopsy tissue posing the diagnostic dilemma in conventional histopathology were included in the study. Immunohistochemistry was performed wherever necessary.
Results During the study period, we encountered 32 cases of brain biopsy. Five cases posing diagnostic challenges in histopathological diagnosis were included in the study. Expert opinions of neuropathologists were taken in all of these cases. We reviewed the cases for the diagnostic difficulties. A review of all these cases has impacted further treatment.
Conclusion In this case series, we present five CNS tumors with a diagnostic dilemma in histopathological diagnosis where clinicoradiological correlation, immunohistochemistry, and expert opinion helped in the definitive diagnosis revealing the importance of a multidisciplinary approach for the better management of patients.
Source(s) of Support
Nil.
Publication History
Received: 05 November 2021
Accepted: 18 December 2021
Article published online:
09 February 2022
© 2022. Nitte (Deemed to be University). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Gupta T, Epari S, Moiyadi A. et al. Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: retrospective audit from an academic neuro-oncology unit. Indian J Cancer 2017; 54 (04) 594-600
- 2 Anvari K, Bahadorkhan G, Samini F, Izadpanahi P, Bayatmokhtari N, Javadinia SA. Pathological diagnostic pitfalls in the verification of brain tumors; can imaging lead to pathology alternation?. Rep Radiother Oncol 2015; 2 (04) e10598
- 3 Stoyanov GS, Petkova L, Dzhenkov DL. A practical approach to the differential diagnosis of intracranial tumors: gross, histology, and immunoprofile-based algorithm. Cureus 2019; 11 (12) e6384
- 4 Mohammed AA, Hamdan AN, Homoud AS. Histopathological profile of brain tumors: a 12-year retrospective study from Madinah, Saudi Arabia. Asian J Neurosurg 2019; 14 (04) 1106-1111
- 5 Louis DN, Perry A, Wesseling P. et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncol 2021; 23 (08) 1231-1251
- 6 Malabeh Q, Abed A, Obeidat T, Abudalu R, Alwaqfi O. Primary meningeal angiosarcoma in a child: imaging findings. J R Nav Med Serv 2018; 25 (03) 66-72
- 7 Cai S, Wu C, Zhang S, Cai S, Wang X. Meningeal angiosarcoma: a case report and review of the literature. Transl Cancer Res 2016; 5 (05) 618-624
- 8 Shih RY, Koeller KK. Embryonal tumors of the central nervous system: from the radiologic pathology archives. Radiographics 2018; 38 (02) 525-541
- 9 Cole BL, Pierson CR. Histopathologic and molecular features of central nervous system embryonal tumors for integrated diagnosis reporting. Surg Pathol Clin 2020; 13 (04) 783-800
- 10 Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 2009; 8 (05) 412-416
- 11 Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD. Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 2010; 120 (05) 553-566
- 12 Malik A, Deb P, Sharma MC, Sarkar C. Neuropathological spectrum of pilocytic astrocytoma: an Indian series of 120 cases. Pathol Oncol Res 2006; 12 (03) 164-171
- 13 Lee KJ, Marchan E, Peterson J. et al. Management and survival of adult patients with pilocytic astrocytoma in the National Cancer Database. World Neurosurg 2018; 112: e881-e887
- 14 Singh S, Amirtham U, Premalata CS, Lakshmaiah KC, Viswanath L, Kumar RV. Spectrum of metastatic neoplasms of the brain: a clinicopathological study in a tertiary care cancer centre. Neurol India 2018; 66 (03) 733-738
- 15 Glitza Oliva I, Tawbi H, Davies MA. Melanoma brain metastases: current areas of investigation and future directions. Cancer J 2017; 23 (01) 68-74
- 16 Shrestha S, Homagain S, Raut A, Sedhain G, Bhatta S, Shrivastav S. Giant cell glioblastoma in 6-year-old kid: report of an unusual case. Clin Case Rep 2020; 8 (12) 2936-2940
- 17 Belsuzarri TA, Araujo JF, Catanoce AP. et al. Giant cells glioblastoma: case report and pathological analysis from this uncommon subtype of glioma. Rare Tumors 2015; 7 (01) 5634